Biosorption-based 64Cu-labeling of bacteria for pharmacokinetic positron-emission tomography

Int J Pharm. 2020 Nov 30:590:119950. doi: 10.1016/j.ijpharm.2020.119950. Epub 2020 Oct 4.

Abstract

Biosorption-based bacterial 64Cu-labeling and its application in pharmacokinetic positron-emission tomography (PET) were investigated. Both gram-positive and gram-negative bacteria were efficiently labeled with [64Cu]Cu2+ ion in saline at room temperature within 5 min. The labeling ratio for Escherichia coli drastically decreased with trypsin pretreatment and the co-presence of excess Cu2+ ion, indicating the existence of specific Cu2+ binding sites on the E. coli cell surface. Washing with lysogeny broth medium was effective in purifying 64Cu-labeled E. coli for kinetic study; the labeling stability was approximately 90% in serum for 15 min. According to dynamic PET imaging in colon-26 tumor-bearing mice, 64Cu-labeled E. coli immediately disappeared from the blood circulation and primarily accumulated in the liver. In addition, transient pulmonary distribution was observed, being in a dose-dependently accelerated manner. Considering the simplicity and versatility of biosorption-based bacterial 64Cu-labeling without genetic modification, the early-phase pharmacokinetic PET with 64Cu-labeled bacteria is promising for assessing toxicological aspects of bacteria-mediated cancer therapy as well as a variety of bacterial pathogenicities in infectious diseases.

Keywords: (64)Cu-radiolabeling; Bacteria; Biosorption; Pharmacokinetics; Positron-emission tomography.

MeSH terms

  • Animals
  • Anti-Bacterial Agents*
  • Cell Line, Tumor
  • Escherichia coli*
  • Gram-Negative Bacteria
  • Gram-Positive Bacteria
  • Mice
  • Positron-Emission Tomography

Substances

  • Anti-Bacterial Agents